Literature DB >> 19433562

NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

J Pannu1, A McCarthy, A Martin, T Hamouda, S Ciotti, A Fothergill, J Sutcliffe.   

Abstract

NB-002 is an oil-in-water emulsion designed for use for the treatment of skin, hair, and nail infections. The activity of NB-002 was compared to the activities of the available antifungal drugs against the major dermatophytes responsible for cutaneous infections, Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum spp., as well as 12 other genera of filamentous fungi. NB-002 consistently displayed fungicidal activity against all dermatophytes. The comparator compounds were either fungistatic or fungicidal, and for some strain-drug combinations, tolerance was observed. Assessment of the development of spontaneous resistance to NB-002 in different dermatophyte species yielded few stably resistant mutants. For filamentous nondermatophyte fungi, the MIC range varied from 0.06 to 0.5 microg/ml for Alternaria spp. to 2 to 8 microg/ml for Paecilomyes spp. NB-002 had activity against both azole-susceptible and -resistant Candida albicans yeast isolates, with MIC(90)s of 2 microg/ml, respectively, and minimum fungicidal concentrations at which 90% of isolates are inhibited of 4 and 8 microg/ml, respectively. The kinetics of the fungicidal activity of NB-002 against T. rubrum isolates were compared to those of the other antifungal drugs. NB-002 killed both mycelia and microconidia even when the fungal forms were dormant or not actively growing. Electron micrographs of mycelia and spores treated with NB-002 showed the significant disruption of the fungal structure. The in vitro broad coverage of NB-002 against filamentous fungi, dermatophytes, and C. albicans, as well as its rapid fungicidal activity, warrants further investigations to ascertain if NB-002 would be useful for the treatment of cutaneous mycoses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433562      PMCID: PMC2715584          DOI: 10.1128/AAC.00218-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli.

Authors:  T Hamouda; J R Baker
Journal:  J Appl Microbiol       Date:  2000-09       Impact factor: 3.772

2.  A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi.

Authors:  T Hamouda; A Myc; B Donovan; A Y Shih; J D Reuter; J R Baker
Journal:  Microbiol Res       Date:  2001       Impact factor: 5.415

3.  Tinea capitis in the United States: Diagnosis, treatment, and costs.

Authors:  Dong-Churl Suh; Sheila Fallon Friedlander; Monika Raut; Jane Chang; Lien Vo; Hyun-Chul Shin; Amir Tavakkol
Journal:  J Am Acad Dermatol       Date:  2006-12       Impact factor: 11.527

4.  [Onychomycoses caused by non-dermatophytic filamentous fungi in Cádiz].

Authors:  P García-Martos; I Domínguez; P Marín; M Linares; J Mira; J Calap
Journal:  Enferm Infecc Microbiol Clin       Date:  2000 Aug-Sep       Impact factor: 1.731

5.  A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species.

Authors:  T Hamouda; M M Hayes; Z Cao; R Tonda; K Johnson; D C Wright; J Brisker; J R Baker
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Resistance mechanisms in clinical isolates of Candida albicans.

Authors:  Theodore C White; Scott Holleman; Francis Dy; Laurence F Mirels; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

Authors:  M A Ghannoum; R A Hajjeh; R Scher; N Konnikov; A K Gupta; R Summerbell; S Sullivan; R Daniel; P Krusinski; P Fleckman; P Rich; R Odom; R Aly; D Pariser; M Zaiac; G Rebell; J Lesher; B Gerlach; G F Ponce-De-Leon; A Ghannoum; J Warner; N Isham; B Elewski
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

Review 8.  Topical treatment of common superficial tinea infections.

Authors:  Andrew Weinstein; Brian Berman
Journal:  Am Fam Physician       Date:  2002-05-15       Impact factor: 3.292

9.  Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.

Authors:  C Lass-Flörl; M Nagl; C Speth; H Ulmer; M P Dierich; R Würzner
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

10.  The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.

Authors:  Andrzej Myc; Thomas Vanhecke; Jeffrey J Landers; Tarek Hamouda; James R Baker
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

View more
  12 in total

Review 1.  Transungual permeation: current insights.

Authors:  Ronak S Bhuptani; Ketaki M Deshpande; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

Review 2.  Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.

Authors:  Agrawal Vikas; Patel Rashmin; Patel Mrunali; Rahul B Chavan; Thanki Kaushik
Journal:  AAPS PharmSciTech       Date:  2020-01-14       Impact factor: 3.246

3.  New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei.

Authors:  Trygve Brautaset; Håvard Sletta; Kristin F Degnes; Olga N Sekurova; Ingrid Bakke; Olga Volokhan; Trygve Andreassen; Trond E Ellingsen; Sergey B Zotchev
Journal:  Appl Environ Microbiol       Date:  2011-07-15       Impact factor: 4.792

4.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

Review 5.  Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy.

Authors:  Palanivel Ganesan; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2016-05-11

6.  Hydroxychavicol: A phytochemical targeting cutaneous fungal infections.

Authors:  Intzar Ali; Naresh Kumar Satti; Prabhu Dutt; Rajendra Prasad; Inshad Ali Khan
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

7.  Effects of Carbopol® 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study.

Authors:  Yin Zheng; Wu-Qing Ouyang; Yun-Peng Wei; Shahid Faraz Syed; Chao-Shuang Hao; Bo-Zhen Wang; Yan-Hong Shang
Journal:  Int J Nanomedicine       Date:  2016-11-10

8.  Alkyl Protocatechuate-Loaded Nanostructured Lipid Systems as a Treatment Strategy for Paracoccidioides brasiliensis and Paracoccidioides lutzii In Vitro.

Authors:  Kaila P Medina-Alarcón; Junya L Singulani; Aline R Voltan; Janaina C O Sardi; Maicon S Petrônio; Mariana B Santos; Carlos R Polaquini; Luis O Regasini; Vanderlan S Bolzani; Dulce H S da Silva; Marlus Chorilli; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2017-06-12       Impact factor: 5.640

Review 9.  Newer Topical Treatments in Skin and Nail Dermatophyte Infections.

Authors:  Kanika Sahni; Sanjay Singh; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

Review 10.  Novel Drug Delivery Strategies for the Treatment of Onychomycosis.

Authors:  Rupinder K Dhamoon; Harvinder Popli; Madhu Gupta
Journal:  Pharm Nanotechnol       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.